6don MSN
GSK’s pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
5d
Everyday Health on MSNNew UTI Antibiotic Is the First Approved by the FDA in Nearly 30 YearsKey TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
1d
Verywell Health on MSNA New FDA-Approved Antibiotic May Help Women With Recurring UTIsIf you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
In two studies with over 3,000 women and children who had a mild UTI, Blujepa, a pill taken twice a day for five days, worked as well as or better than nitrofurantoin, a common UTI antibiotic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results